Unkart Edward W 4
4 · KalVista Pharmaceuticals, Inc. · Filed Oct 5, 2018
Insider Transaction Report
Form 4
Unkart Edward W
Director
Transactions
- Award
Director Stock Option (Right to Buy)
2018-10-03+7,000→ 7,000 totalExercise: $22.65Exp: 2028-10-02→ Common Stock (7,000 underlying)
Footnotes (1)
- [F1]The option vests over a 12 month period: 1/12th on November 3, 2018, after which 1/12th of the total shares vest monthly, subject to continued service through each vesting date.